Huntington Disease Center

From European Huntington Association: Join us for an open webinar with Novartis to get the latest updates on the INVEST-HD trial, including timeline updates and insights from a clinical perspective. Featuring presentations by Beth Borowsky, Senior Global Programme Clinical Head in Neuroscience at Novartis, and Åsa Petersén, MD…

Sofia Bergh, PhD student in Åsa Petersén’s research group at Lund University, will defend her dissertation in May. One part of the studies during the past four years has been to test the hypothesis that hypothalamus is vulnerable to mutant huntingtin and to the protein TDP-43. Time: Wednesday…

For the first time ever, the four Swedish patients’ organizations for Alzheimer’s, Huntington, Parkinson’s and ALS are arranging a joint conference on neurodegenerative diseases. Åsa Petersén, Professor and Senior Consultant in Psychiatry, and Håkan Widner, Professor and Senior Consultant in Neurology, both active at the Huntington Disease Centre…

Åsa Petersén has been interviewed by the website “Vetenskap & Hälsa” (Science & Health) about Huntington’s disease and the ongoing research to find a future treatment. Recent research has come up with some interesting findings, which are crucial for the development of efficient treatments Link to the pod…

The Swedish patients’ organisation, RHS, held their yearly meeting in October 2025 and Professor Åsa Petersén was invited speaker. Petersén’s talk addressed early symptoms in HD connected to research. The meeting was recorded and the films are now available on RHS’ website. Link to the content at RHS’…

Petersén is invited to give a talk at the 2025 Family Gathering for the Scottish Huntington’s Association with around 170 attendees on November 8, 2025 in Glasgow. Link to the programme at the association’s webpage (opens in a new window)

The Swedish channel TV4 published the news on the HD clinical trials that were positively described in media in late September. Professor Åsa Petersén was interviewed about the findings by TV4 and she emphasizes the need for cautiousness when interpreting the results, as they are not yet published…